| no |
title |
author |
magazine |
year |
volume |
issue |
page(s) |
type |
| 1 |
ADMA and hyperhomocysteinemia
|
Dayal, Sanjana
|
|
2005
|
10 |
1 |
p. S27-S33
|
article
|
| 2 |
ADMA and oxidative stress may relate to the progression of renal disease: rationale and design of the VIVALDI study
|
Böger, Rainer H
|
|
2005
|
10 |
1 |
p. S97-S102
|
article
|
| 3 |
ADMA: an emerging cardiovascular risk factor
|
Böger, Rainer H
|
|
2005
|
10 |
1 |
p. S1-S2
|
article
|
| 4 |
ADMA: its role in vascular disease
|
Cooke, John P
|
|
2005
|
10 |
1 |
p. S11-S17
|
article
|
| 5 |
ADMA metabolism and clearance
|
Teerlink, Tom
|
|
2005
|
10 |
1 |
p. S73-S81
|
article
|
| 6 |
ADMA regulates angiogenesis: genetic and metabolic evidence
|
Achan, V
|
|
2005
|
10 |
1 |
p. 7-14
|
article
|
| 7 |
Annual Scientific Sessions of the Society for Vascular Medicine and Biology a Conjoint Meeting with the North American Vascular Biology Organization
|
|
|
2005
|
10 |
1 |
p. 81-82
|
article
|
| 8 |
Arginine metabolism in vascular biology and disease
|
Morris, Sidney M
|
|
2005
|
10 |
1 |
p. S83-S87
|
article
|
| 9 |
Asymmetric dimethylarginine (ADMA) accelerates cell senescence
|
Bode-Böger, Stefanie M
|
|
2005
|
10 |
1 |
p. S65-S71
|
article
|
| 10 |
Asymmetric dimethylarginine (ADMA) and cardiovascular disease: insights from prospective clinical trials
|
Böger, Rainer H
|
|
2005
|
10 |
1 |
p. S19-S25
|
article
|
| 11 |
Calender of events
|
|
|
2005
|
10 |
1 |
p. 79-80
|
article
|
| 12 |
Cellular and molecular mechanisms of coronary vessel development
|
Mu, Hong
|
|
2005
|
10 |
1 |
p. 37-44
|
article
|
| 13 |
DDAH gene and cardiovascular risk
|
Valkonen, Veli-Pekka
|
|
2005
|
10 |
1 |
p. S45-S48
|
article
|
| 14 |
Endogenous production of nitric oxide synthase inhibitors
|
Anthony, Shelagh
|
|
2005
|
10 |
1 |
p. S3-S9
|
article
|
| 15 |
Endovascular treatment of an occluded axillofemoral bypass graft
|
Slovut, David P
|
|
2005
|
10 |
1 |
p. 33-36
|
article
|
| 16 |
Hyperhomocyst(e)inemia impairs angiogenesis in a murine model of limb ischemia
|
Bosch-Marcé, Marta
|
|
2005
|
10 |
1 |
p. 15-22
|
article
|
| 17 |
Images in vascular medicine
|
Chi, Yung-Wei
|
|
2005
|
10 |
1 |
p. 59-60
|
article
|
| 18 |
Images in vascular medicine
|
Giesel, Frederik L
|
|
2005
|
10 |
1 |
p. 55-57
|
article
|
| 19 |
Images in vascular medicine
|
Böckler, Dittmar
|
|
2005
|
10 |
1 |
p. 61-62
|
article
|
| 20 |
Images in vascular ultrasound
|
Olin, Jeffrey W
|
|
2005
|
10 |
1 |
p. 63-64
|
article
|
| 21 |
Insulin resistance: potential role of the endogenous nitric oxide synthase inhibitor ADMA
|
Sydow, Karsten
|
|
2005
|
10 |
1 |
p. S35-S43
|
article
|
| 22 |
Pharmacotherapies and their influence on asymmetric dimethylargine (ADMA)
|
Maas, Renke
|
|
2005
|
10 |
1 |
p. S49-S57
|
article
|
| 23 |
Plasma levels and zymographic activities of matrix metalloproteinases 2 and 9 in type II diabetics with peripheral arterial disease
|
Signorelli, Salvatore Santo
|
|
2005
|
10 |
1 |
p. 1-6
|
article
|
| 24 |
Point-of-care (POC) versus central laboratory instrumentation for monitoring oral anticoagulation
|
Dorfman, David M
|
|
2005
|
10 |
1 |
p. 23-27
|
article
|
| 25 |
Quantification of ADMA: analytical approaches
|
Schwedhelm, Edzard
|
|
2005
|
10 |
1 |
p. S89-S95
|
article
|
| 26 |
SCAI/SVMB/SVS Clinical Competence Statement
|
Rosenfield, K
|
|
2005
|
10 |
1 |
p. 65-75
|
article
|
| 27 |
Spotlight on endothelial progenitor cell inhibitors: short review
|
Thum, Thomas
|
|
2005
|
10 |
1 |
p. S59-S64
|
article
|
| 28 |
The role of inflammation in atherothrombosis: implications for clinical practice
|
Tedgui, Alain
|
|
2005
|
10 |
1 |
p. 45-53
|
article
|
| 29 |
Treprostinil for the treatment of severe digital necrosis in systemic sclerosis
|
Engel, Gregory
|
|
2005
|
10 |
1 |
p. 29-32
|
article
|
| 30 |
Vascular viewpoint
|
Mohammed, Naufal
|
|
2005
|
10 |
1 |
p. 77-78
|
article
|
Journal description